Literature DB >> 23392716

Over-expression of heme oxygenase-1 does not protect porcine endothelial cells from human xenoantibodies and complement-mediated lysis.

Chi Zhang1,2, Lu Wang1, Shan Zhong1, Xiao-Xiao Wang1, Ying Xiang1, Shi Chen1,3,4, Gang Chen5,6,7.   

Abstract

Accommodated organs can survive in the presence of anti-organ antibodies and complement. Heme oxygenase-1 (HO-1) is essential to ensure accommodation in concordant xenotransplant models. However, whether induction of HO-1 over-expression could protect porcine endothelial cells (PECs) against human xenoantibodies and complement-mediated lysis and induce an in vitro accommodation is still unknown. The SV40-immortalized porcine aorta-derived endothelial cell line (iPEC) was pre-incubated with 20, 50, or 80 μmol/L of cobalt-protoporphyrins IX (CoPPIX) for 24 h, and the HO-1 expression in iPECs was analyzed by using Western blotting. CoPPIX-treated or untreated iPECs were incubated with normal human AB sera, and complement-dependent cytotoxicity (CDC) was measured by both flow cytometry and lactate dehydrogenase (LDH) release assay. In vitro treatment with CoPPIX significantly increased the expression of HO-1 in iPECs in a dose-dependent manner. Over-expression of HO-1 was successfully achieved by incubation of iPECs with either 50 or 80 μmol/L of CoPPIX. However, HO-1 over-expression did not show any protective effects on iPECs against normal human sera-mediated cell lysis. In conclusion, induction of HO-1 over-expression alone is not enough to protect PECs from human xenoantibodies and complement-mediated humoral injury. Additionally, use of other protective strategies is needed to achieve accommodation in pig-to-primate xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392716     DOI: 10.1007/s11596-013-1079-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  16 in total

Review 1.  Accommodation.

Authors:  M P Soares; Y Lin; K Sato; K M Stuhlmeier; F H Bach
Journal:  Immunol Today       Date:  1999-10

2.  The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy.

Authors:  Gang Chen; Hongtao Sun; Hongji Yang; Dalibor Kubelik; Bertha Garcia; Yigang Luo; Ying Xiang; Allen Qian; Laura Copeman; Weihua Liu; Carl J Cardella; Wanyu Wang; Yuliang Xiong; William Wall; David J White; Robert Zhong
Journal:  Transplantation       Date:  2006-01-27       Impact factor: 4.939

3.  Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression.

Authors:  Christine Chauveau; Séverine Rémy; Pierre Joseph Royer; Marcelo Hill; Séverine Tanguy-Royer; François-Xavier Hubert; Laurent Tesson; Régis Brion; Gaëlle Beriou; Marc Gregoire; Régis Josien; Maria Cristina Cuturi; Ignacio Anegon
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

4.  Inhibition of complement-mediated porcine endothelial cell cytotoxicity by human IgM natural antibody.

Authors:  A P Dalmasso; T He; B A Benson
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

5.  Is the ABO incompatibility a risk factor in bone marrow transplantation?

Authors:  Primoz Rozman; Andrej Kosir; Mateja Bohinjec
Journal:  Transpl Immunol       Date:  2005-04-26       Impact factor: 1.708

6.  The in vitro protection of human decay accelerating factor and hDAF/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of Formosan macaques.

Authors:  C-F Tu; H-C Tai; C-P Wu; L-L Ho; Y-J Lin; C-S Hwang; T-S Yang; J-M Lee; Y-L Tseng; C-C Huang; C-N Weng; P-H Lee
Journal:  Transplant Proc       Date:  2010 Jul-Aug       Impact factor: 1.066

7.  Induction of xenograft accommodation by modulation of elicited antibody responses1 2.

Authors:  Ning Wang; Jang Ming Lee; Edda Tobiasch; Eva Csizmadia; Neal R Smith; Bend Gollackes; Simon C Robson; Fritz H Bach; Yuan Lin
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

8.  Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan.

Authors:  Kota Takahashi; Kazuhide Saito; Shiro Takahara; Akihiko Okuyama; Kazunari Tanabe; Hiroshi Toma; Kazuharu Uchida; Akira Hasegawa; Norio Yoshimura; Yoriaki Kamiryo
Journal:  Am J Transplant       Date:  2004-07       Impact factor: 8.086

9.  Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation.

Authors:  Min Zhu; Wei Zhang; Fang Liu; Lu Wang; Bin Liu; Dong Chen; Xue-Hai Zhu; Wei-Jie Zhang; Thomas E Ichim; Zhi-Shui Chen; Ping Zhou; Shi Chen; Gang Chen
Journal:  Transpl Immunol       Date:  2008-07-01       Impact factor: 1.708

10.  ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation.

Authors:  Douglas W Hanto; Annie H Fecteau; Maria H Alonso; John F Valente; James F Whiting
Journal:  Liver Transpl       Date:  2003-01       Impact factor: 5.799

View more
  1 in total

1.  IL-4 and IL-13 induce protection from complement and melittin in endothelial cells despite initial loss of cytoplasmic proteins: membrane resealing impairs quantifying cytotoxicity with the lactate dehydrogenase permeability assay.

Authors:  Barbara A Benson; Gregory M Vercellotti; Agustin P Dalmasso
Journal:  Xenotransplantation       Date:  2015-06-01       Impact factor: 3.907

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.